🇺🇸 FDA
Patent

US 8853228

Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase

granted A61PA61P31/04A61P31/10

Quick answer

US patent 8853228 (Heterocyclic analogs of propargyl-linked inhibitors of dihydrofolate reductase) held by UNIVERSITY OF CONNECTICUT expires Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
UNIVERSITY OF CONNECTICUT
Grant date
Tue Oct 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
24
CPC classes
A61P, A61P31/04, A61P31/10, A61P33/02, A61P35/00